- ENGN Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
enGene (ENGN) CORRESPCorrespondence with SEC
Filed: 28 Sep 23, 12:00am
enGene Holdings Inc.
7171 Rue Frederick Banting
Saint-Laurent, QC H4S 1Z9, Canada
September 28, 2023
U.S. Securities and Exchange Commission
Division of Corporate Finance
100 F Street NE
Washington, DC 20549
Attention: Doris Stacey Gama
VIA EDGAR
Re: | enGene Holdings Inc. |
Registration Statement on Form S-4 |
Filed August 9, 2023 |
File No. 333-273851 |
Dear Ms. Gama:
In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of Amendment No. 2 to the Registration Statement on Form S-4 (File No. 333-273851) (the “Registration Statement”) of enGene Holdings Inc. We respectfully request that the Registration Statement become effective as of 10:00 a.m., Eastern time, on September 29, 2023, or as soon as practicable thereafter.
Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Morgan, Lewis & Bockius LLP, by calling Howard Kenny at +1.212.309.6843 or Thurston J. Hamlette at +1.212.309.6240.
Very Truly Yours, | ||
enGene Holdings Inc. | ||
By: | /s/ Jason D. Hanson | |
Name: | Jason D. Hanson | |
Title: | Chief Executive Officer |
cc: | Morgan, Lewis & Bockius LLP |